A Agilent Technologies Inc.

Agilent Collaborates with METTLER TOLEDO to Reduce Errors in Sample Preparation Workflows for Better Chromatographic Results

(NYSE: A) today announced that it is collaborating with METTLER TOLEDO to address one of the biggest concerns in any laboratory—error-prone sample preparation. This integrated solution allows the automatic and seamless transfer of weighing results and the associated metadata from METTLER TOLEDO LabX™ Balance software to Agilent OpenLab software.

Sample preparation is a critical part of many laboratory workflows. It is a time-consuming bottleneck and a frequent source of errors and inaccuracies that often leads to costly quality investigations or rework. This solution from Agilent and METTLER TOLEDO, launched in Munich at Analytica 2022 in June, offers a fully automated and digitalized LC or GC workflow designed to eliminate common errors in the weighing process.

The complete solution automatically transfers weighing results to the latest release of Sample Scheduler for Agilent OpenLab CDS. Sample Scheduler retrieves the sample and weight data from the METTLER TOLEDO LabX software and allows users to seamlessly route sample and weighing information to any instrument in the laboratory.

“We are pleased to announce this collaboration with METTLER TOLEDO,” said Jacob Thaysen, president, Agilent's Life Sciences and Applied Markets Group. He added, “This new sample preparation workflow not only improves results, but it also offers a truly digital user experience for operating chromatographic instruments—helping our customers build their labs of the future.”

“This is a prime example of how two prevalent vendors of lab equipment have collaborated to address one of the biggest concerns in the laboratory,” said Patrick Kaltenbach, CEO of METTLER TOLEDO. “The seamless integration of balances and chromatography instruments in a digital and automated sample preparation and analysis process allows a drastic reduction or even elimination of transcription and calculation errors, significantly increasing lab productivity.”

By addressing one of the biggest, most basic laboratory challenges—transferring weighing results accurately to other lab systems—the Agilent/METTLER TOLEDO solution will accelerate the digital transformation of laboratories.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on , , and .

EN
01/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Agilent Technologies, Inc.: Update to credit analysis

Our credit view of this issuer reflects its low financial leverage, against its high proportion of revenue from costly equipment sales, which has exposure to cyclical demand fluctuations

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 December 2025 in which we reassessed the appropriateness of the ratings in th...

Agilent Technologies Inc: 1 director

A director at Agilent Technologies Inc sold 2,600 shares at 149.812USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

6550-6569 S&P 500 Support Holding For Now After 5.5-months, the S&P 500 (SPX) has now failed to break and stay below the its 20-day MA. However, 6569 has been our level that needs to break in order for us to have confidence that a pullback has begun; SPX made a low of 6551 on Friday (less than 20 points or 0.3% from our 6569 level), meaning it was not a decisive breakdown (in time or price). As a result, our near-term bullish outlook since our 4/22/25 Compass remains intact, and it will stay t...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch